Live Breaking News & Updates on Biopharmaceutical sales

Stay updated with breaking news from Biopharmaceutical sales. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MGRC bags Covid-19 surveillance contract from Health Ministry

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd was awarded a Covid-19 surveillance contract by the Health Ministry's biomedical research arm, the Institute of Medical Research.

Kuala-lumpur , Malaysia , Malaysian , Datuk-alvin-nesakumar , Institute-of-medical-research , Malaysian-genomics-resource-centre-bhd , Health-ministry , Malaysian-genomics-resource-centre , Malaysian-genomics , Biosafety-level , Current-good-manufacturing-practice , Corporate-news

Heat Biologics Provides Year-End 2021 Business Update

Jeff Wolf, Chief Executive Officer of Heat, commented, “2021 was a transformative year for Heat as we progress our strategic evolution to become a fully-integrated biopharmaceutical company.

United-states , San-antonio , Texas , Canada , American , David-waldman , Jeff-wolf , Skunkworx-bio , Twitter , Scorpion-biological-services , American-association-of-cancer-research , Heat-biologics-inc

COVID-19 vaccine from Anhui earns conditional approval

China has given conditional approval for a recombinant protein subunit COVID-19 vaccine developed by domestic company Anhui Zhifei Longcom Biopharmaceutical, the National Medical Products Administration said on Wednesday.

China , Hefei , Anhui , Anhui-zhifei-longcom , National-medical-products-administration , Anhui-zhifei-longcom-biopharmaceutical-co-ltd , Anhui-zhifei-longcom-biopharmaceutical , Vaccine , Covid-19 , Protein , Approved , National

Biopharmaceutical CMO And CRO Market Size Worth $54.1 Billion By 2030: Grand View Research, Inc.

SAN FRANCISCO, Feb. 8, 2022 /PRNewswire/ -- The global biopharmaceutical CMO and CRO market size is expected to reach USD 54.1 billion by 2030, registering a CAGR of 6.6% over the forecast period

Germany , United-states , Brazil , California , South-africa , Canada , France , Grand-view , San-francisco , America , Biologics-sdn-bhd , Samsung-biologics

US Capital Global Securities Closes $10MM Financing for Cardax, Inc.

Global private financial group supports the growth of development-stage biopharmaceutical company combatting cardiovascular disease, arthritis, and ageing.

Honolulu , Hawaii , United-states , California , San-francisco , Charles-towle , Us-capital-global-securities , Cardax-inc , Global-securities , Arthritis , Asset-management , Banks

Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110

Download as PDF January 12, 2022 Data demonstrates that PTX-35 may have utility in solid organ transplantation, and to potentially slow or mitigate deleterious immune responses where self-tissue tolerance is impaired.

United-states , Canada , American , David-waldman , James-shapiro , Jeff-wolf , Clinical-islet-transplant-program , University-of-alberta , Twitter , Heat-biologics-inc , Department-of-surgery , American-journal

Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China

STRO-002 is a FolRα-targeting antibody-drug conjugate (ADC), currently in clinical studies for patients with ovarian and endometrial cancers in the U.S. and Europe.

Germany , Taiwan , Shanghai , China , Hong-kong , United-kingdom , Canada , Macau , Chinese , Sutro-biopharma , Anniej-chang , Sutro-xpress